1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow CytRx: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia Tamibarotene, Arsenic trioxide - Acute Promyelocytic Leukemia | Phase 1 | Terminated | Northwestern University | 4 | 2009-10-01 | 2013-10-30 |
| Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia INNO-406 - Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 | Completed | CytRx | 100 | 2006-07-01 | 2009-06-01 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Promyelocytic, Acute (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Arsenic Trioxide (1) · bafetinib (1) · tamibarotene (1)
United States (2) · Germany (1) · Israel (1)